Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on TransMedics Group, Raises Price Target to $63

Morgan Stanley analyst Cecilia Furlong maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $54 to $63.
byBenzinga Newsdesk
January 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Cecilia Furlong maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $54 to $63.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts